These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 28256403)

  • 61. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serial scanning with technetium pyrophosphate (
    Castaño A; DeLuca A; Weinberg R; Pozniakoff T; Blaner WS; Pirmohamed A; Bettencourt B; Gollob J; Karsten V; Vest JA; Chiuzan C; Maurer MS; Bokhari S
    J Nucl Cardiol; 2016 Dec; 23(6):1355-1363. PubMed ID: 26453570
    [TBL] [Abstract][Full Text] [Related]  

  • 63. New quantitative indices of cardiac amyloidosis with
    Matsuda N; Otsuka H; Otani T; Azane S; Kunikane Y; Otomi Y; Ueki Y; Kubota M; Amano M; Yagi S; Sata M; Harada M
    Jpn J Radiol; 2023 Apr; 41(4):428-436. PubMed ID: 36449252
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
    Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S
    Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence of Positive
    Kim HM; Sohn DW; Paeng JC
    Int Heart J; 2019 May; 60(3):643-647. PubMed ID: 31019172
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
    Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
    Hanna M; Ruberg FL; Maurer MS; Dispenzieri A; Dorbala S; Falk RH; Hoffman J; Jaber W; Soman P; Witteles RM; Grogan M
    J Am Coll Cardiol; 2020 Jun; 75(22):2851-2862. PubMed ID: 32498813
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
    Chen W; Ton VK; Dilsizian V
    Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis.
    Park YJ; Lee J; Kim D; Choi JO; Kim SJ; Kim K; Choi JY
    BMC Med Imaging; 2023 Jul; 23(1):92. PubMed ID: 37460984
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiac scintigraphy with
    de Haro-Del Moral FJ; Pubul-Núñez V; Casáns-Tormo I; Jiménez-Heffernan A; Ruano-Pérez R
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):254-266. PubMed ID: 32513587
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnostic value of heart-to-mediastinum ratio in
    Ikoma T; Ohtani H; Ohno K; Iguchi K; Suwa K; Sawada M; Tanahashi Y; Sakamoto A; Saotome M; Ichikawa S; Goshima S; Maekawa Y
    J Nucl Cardiol; 2023 Aug; 30(4):1374-1381. PubMed ID: 36547805
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantitative Comparison Between Amyloid Deposition Detected by (99m)Tc-Diphosphonate Imaging and Myocardial Deformation Evaluated by Strain Echocardiography in Transthyretin-Related Cardiac Amyloidosis.
    Di Bella G; Minutoli F; Piaggi P; Casale M; Mazzeo A; Zito C; Oreto G; Baldari S; Vita G; Pingitore A; Khandheria BK; Carerj S
    Circ J; 2016 Aug; 80(9):1998-2003. PubMed ID: 27477961
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis.
    Tanaka K; Essick EE; Doros G; Tanriverdi K; Connors LH; Seldin DC; Sam F
    J Am Heart Assoc; 2013 Mar; 2(2):e005868. PubMed ID: 23537813
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy.
    Longhi S; Bonfiglioli R; Obici L; Gagliardi C; Milandri A; Lorenzini M; Guidalotti PL; Merlini G; Rapezzi C
    Clin Nucl Med; 2015 May; 40(5):446-7. PubMed ID: 25742226
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
    Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
    JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inter-observer reproducibility and intra-observer repeatability in
    Singh V; Cuddy S; Kijewski MF; Park MA; Taylor A; Taqueti VR; Skali H; Blankstein R; Falk RH; Di Carli MF; Dorbala S
    J Nucl Cardiol; 2022 Apr; 29(2):440-446. PubMed ID: 32918247
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis.
    Rauf MU; Hawkins PN; Cappelli F; Perfetto F; Zampieri M; Argiro A; Petrie A; Law S; Porcari A; Razvi Y; Bomsztyk J; Ravichandran S; Ioannou A; Patel R; Starr N; Hutt DF; Mahmood S; Wisniowski B; Martinez-Naharro A; Venneri L; Whelan C; Roczenio D; Gilbertson J; Lachmann HJ; Wechalekar AD; Rapezzi C; Serenelli M; Massa P; Caponetti AG; Ponziani A; Accietto A; Giovannetti A; Saturi G; Sguazzotti M; Gagliardi C; Biagini E; Longhi S; Fontana M; Gillmore JD
    Eur Heart J; 2023 Jun; 44(24):2187-2198. PubMed ID: 36946431
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-Amylo.
    Arana-Achaga X; Goena-Vives C; Villanueva-Benito I; Solla-Ruiz I; Rengel Jimenez A; Gaspar TI; Urreta-Barallobre I; Barge-Caballero G; Seijas-Marcos S; Cabrera E; Garcia-Pavía P; Basurte Elorz MT; Ayestarán NM; Sierra LT; Robledo Iñarritu M; Lozano-Bahamonde A; Escolar-Perez V; Gómez-Ramírez C; Alzola E; Andrés RN; Francisco Matias JL; Limeres Freire J; Armengou Arxe A; Negre Busó M; Piqueras-Flores J; Martínez-Del Río J; Onaindia Gandarias JJ; Rodriguez Sanchez I; Querejeta Iraola R
    JACC Cardiovasc Imaging; 2023 Dec; 16(12):1567-1580. PubMed ID: 37389511
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease.
    Azevedo Coutinho MC; Cortez-Dias N; Cantinho G; Gonçalves S; Menezes MN; Guimarães T; Lima da Silva G; Francisco AR; Agostinho J; Santos L; Conceição I; Pinto FJ
    Amyloid; 2020 Sep; 27(3):174-183. PubMed ID: 32482106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.